Critical role of β3 integrin in experimental postmenopausal osteoporosis

Haibo Zhao, Hideki Kitaura, Mark S. Sands, F. Patrick Ross, Steven L. Teitelbaum, Deborah Veis Novack

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

We show that mice lacking β3 integrin are protected from OVX-induced bone loss. Using a lentiviral-based strategy to express β3 mutants in β3-/- mice, we also show that β3S752, but not β3Y747/Y59, is important for osteoclastic bone resorption in vivo. Introduction: Mice lacking the β3 integrin have dysfunctional osteoclasts and therefore accumulate bone mass with age. Thus, the αvβ3 integrin is a potential anti-osteoporosis target. Identifying components of the β3 integrin that determine its function in vivo is essential for therapeutically exploiting the antiresorptive properties of αvβ3. Materials and Methods: We used DXA and histomorphometry to assess bone loss after ovariectomy in wildtype and β3 integrin null mice. We used lentiviral vectors carrying various human β3 (hβ3) integrin constructs to transduce β3-/- bone marrow and reconstituted lethally irradiated β3-/- mice with the transduced marrow. The expressed constructs include the intact integrin and two mutants, namely hβ3Y747F/Y759F and hβ3 S752P, each of which induces the bleeding dyscrasia, Glanzmann's thrombasthenia, in humans. Two months after transplantation, the expression of hβ3 was measured by flow cytometry of marrow-derived macrophages. Osteoclast differentiation and function were assessed ex vivo by TRACP and actin-ring staining, respectively. Reconstituted mice were ovariectomized, and bone loss was assessed by DXA, histomorphometry, and serum TRACP5b assay. Results: β3-/- mice are protected from ovariectomy-induced bone loss, showing no difference in BMD compared with sham-operated controls. We successfully expressed hβ3 integrins in β3-/- hosts using lentiviral transduction of bone marrow. Two months after transplantation, 25-35% of marrow-derived macrophages expressed the hβ3 constructs. Similar to its effect in vitro, hβ3WT completely rescued the osteoclast and platelet phenotype of β3-/- mice. Whereas platelet function remained deranged in β3-/- mice overexpressing hβ3 Y747F/Y759F, osteoclast function was fully restored. In contrast, β3-/- mice expressing hβ3S752P continued to exhibit prolonged bleeding times and dysfunctional osteoclasts in vitro and ex vivo. Most importantly, hβ3WT and hβ3Y747F/Y759F transplanted mice underwent equivalent ovariectomy-induced bone loss, whereas, like those bearing the control vector, hβ3S752P transplanted mice were protected. Conclusions: Functional β3 integrin is required for ovariectomy-induced bone loss. β3S752, but not β3 Y747/Y759, is critical for osteoclast function in vivo.

Original languageEnglish
Pages (from-to)2116-2123
Number of pages8
JournalJournal of Bone and Mineral Research
Volume20
Issue number12
DOIs
Publication statusPublished - 2005 Dec 1
Externally publishedYes

Keywords

  • Bone resorption
  • Osteoclasts
  • Osteoporosis
  • Ovariectomy
  • αvβ3 integrin

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine

Fingerprint Dive into the research topics of 'Critical role of β3 integrin in experimental postmenopausal osteoporosis'. Together they form a unique fingerprint.

  • Cite this